ASTS
AST SpaceMobile, Inc.
ASTS has the edge over IMXI overall, supported by stronger modeled upside and stronger fundamentals.
IMXI
International Money Express, Inc.
IMXI trails on the overall score without a compensating advantage in the available component scores.
ASTS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
ASTS's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
IMXI Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Stable | |
| Healthy | |
| Strong |
IMXI's cash flow and balance sheet are currently healthy, and its profitability is stable, but its revenue is under pressure.
ASTS PE Valuation
ASTS has no meaningful PE right now: it lost money over the past year.
IMXI PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 7.4x | $6.39 | — |
| Cheap | 11x | $6.63 | +3.8% |
| Current | 11x | $6.39 | — |
| Fair | 15x | $8.92 | +40% |
| Expensive | 19x | $11.18 | +75% |
Historical ranges are pointers, not guarantees.
IMXI's PE is in its cheap range at 11x. On analysts' estimates for next year's earnings, today's price would be 7.4x.
ASTS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect ASTS's losses to grow, with revenue growing. However, they disagree widely on these estimates.
IMXI Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong decline | |
| Decline | |
| Strongly weakening | |
| Limited | |
| Moderate |
Analysts expect IMXI's earnings and revenue to decline, with profitability weakening.
ASTS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$2.15 | -$0.91 |
| Q2 2026 | -$2.16 | -$0.27 |
| Q1 2026 | -$1.80 | +$0.19 |
| Q4 2025 | -$1.34 | +$0.61 |
| Q3 2025 | -$1.24 | +$0.88 |
| Q2 2025 | -$1.89 | -$0.64 |
| Q1 2025 | -$1.99 | -$1.01 |
| Q4 2022 | -$0.58 | -$0.21 |
ASTS is still losing money, but far less than before: $2.15 per share over the past year, against $5.76 at its worst in mid-2021.
IMXI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.86 | +46% |
| Q3 2026 | $0.59 | -54% |
| Q2 2026 | $0.62 | -62% |
| Q1 2026 | $0.85 | -50% |
| Q4 2025 | $1.08 | -40% |
| Q3 2025 | $1.28 | -28% |
| Q2 2025 | $1.64 | -1.8% |
| Q1 2025 | $1.69 | +1.2% |
| Q4 2024 | $1.79 | +9.8% |
IMXI has the edge over ASTS on earnings quality, reporting a profit while its opponent remains loss making.
ASTS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $42.3M | +187% |
| Q2 2026 | $31.5M | +2627% |
| Q1 2026 | $14.7M | +1952% |
| Q4 2025 | $54.3M | +2731% |
| Q3 2025 | $14.7M | +1240% |
| Q2 2025 | $1.2M | +28% |
| Q1 2025 | $718K | +44% |
| Q3 2022 | $4.2M | +70% |
ASTS has the edge over IMXI on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -415% | +694 points |
| Q2 2026 | -948% | +10744 points |
| Q1 2026 | -1686% | +7083 points |
| Q4 2025 | -175% | +2446 points |
| Q3 2025 | -1109% | +4850 points |
| Q2 2025 | -11692% | -4693 points |
| Q1 2025 | -8769% | +2331 points |
| Q4 2024 | -2621% | N/A |
ASTS's operating margin was −415% last quarter, up 694 points from the same quarter a year ago.
IMXI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $126.4M | -18% |
| Q2 2026 | $131.2M | -19% |
| Q1 2026 | $122M | -15% |
| Q4 2025 | $147.4M | -11% |
| Q3 2025 | $154.9M | -9.9% |
| Q2 2025 | $161.1M | -6.1% |
| Q1 2025 | $144.3M | -4.1% |
| Q4 2024 | $164.8M | -4.1% |
IMXI's revenue has slid since its 2023 peak: $126M last quarter, down 18% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 7.2% | +0.4 points |
| Q2 2026 | 6.7% | -5.4 points |
| Q1 2026 | 3% | -6.7 points |
| Q4 2025 | 7.8% | -7.1 points |
| Q3 2025 | 6.8% | -9.4 points |
| Q2 2025 | 12% | -1.3 points |
| Q1 2025 | 9.8% | -3.3 points |
| Q4 2024 | 15% | -1.1 points |
IMXI has the edge over ASTS on profitability, with a higher operating margin.
ASTS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$464.2M | -$161.4M |
| Q2 2026 | -$694.8M | -$341.1M |
| Q1 2026 | -$309.7M | -$160.7M |
| Q4 2025 | -$330.7M | -$220.3M |
| Q3 2025 | -$302.9M | -$239.1M |
| Q2 2025 | -$353.6M | -$315.3M |
| Q1 2025 | -$149M | -$61.3M |
| Q4 2024 | -$110.5M | -$63.2M |
ASTS has burned cash in almost every quarter: −$1.8B over the past year, against −$916M the year before.
IMXI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $3.3M | +$38.8M |
| Q2 2026 | $107.2M | +203% |
| Q1 2026 | -$42.9M | -219% |
| Q4 2025 | -$20M | -$11.2M |
| Q3 2025 | -$35.5M | -252% |
| Q2 2025 | $35.3M | +$61.6M |
| Q1 2025 | $36M | +3.6% |
| Q4 2024 | -$8.8M | -116% |
IMXI has the edge over ASTS on cash generation, producing positive trailing cash flow while its opponent burns cash.
ASTS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.4% | +1.1M shares |
| 1 year | +10% | +27.3M shares |
| 3 years | +235% | +211M shares |
| 5 years | +480% | +248M shares |
| Available history | +944% | +271M shares |
ASTS has 300M diluted shares, up 10% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
IMXI Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +49.2K shares |
| 1 year | +2.8% | +841K shares |
| 3 years | -15% | -5.4M shares |
| 5 years | -22% | -8.7M shares |
| Available history | -20% | -7.6M shares |
IMXI has the edge over ASTS on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | $11.4M |
| Q1 2025 | $5M |
| Q4 2024 | $20.2M |
IMXI hasn't bought back shares in the past year.
ASTS Net Leverage
ASTS's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
IMXI Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.8x | Net Cash |
| Q2 2026 | -0.7x | Net Cash |
| Q1 2026 | 1.1x | Healthy |
| Q4 2025 | 0.4x | Very low |
| Q3 2025 | 0.1x | Very low |
| Q2 2025 | -0.3x | Net Cash |
| Q1 2025 | -0.0x | Net Cash |
| Q4 2024 | 0.2x | Very low |
IMXI has more cash than debt.
ASTS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 34.1 | Neutral |
| Stochastic | 11.9 | Oversold |
ASTS's weekly RSI is 34 (neutral) and its Stochastic is 12 (oversold).
IMXI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 21.9 | Oversold |
| Stochastic | 7.3 | Oversold |
IMXI's weekly RSI is 22 (oversold) and its Stochastic is 7 (oversold).
ASTS PE vs Technology Sector
ASTS has no meaningful PE right now: it lost money over the past year.
IMXI PE vs Technology Sector
| Metric | IMXI | Sector median | Relative |
|---|---|---|---|
| PE | 11x | 28x | 61% below |
| PE % | 14 | 35 | 21 pts below |
IMXI is trading at 11x earnings, a 61% discount to the Technology sector's median of 28x.
ASTS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $44.9 | 23% below |
| 20 week MA | $57.1 | 40% below |
| 50 week MA | $75.5 | 54% below |
| 100 week MA | $57.8 | 40% below |
| 200 week MA | $33.6 | 2.8% above |
ASTS has the edge over IMXI on trend strength, trading above more of its moving averages.
IMXI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $9.74 | 34% below |
| 20 week MA | $12.1 | 47% below |
| 50 week MA | $14.1 | 55% below |
| 100 week MA | $14.1 | 55% below |
| 200 week MA | $17.6 | 64% below |
IMXI is in a downtrend: it's below all five of its weekly moving averages, and 64% below its 200-week average.
ASTS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.87 | $13.4 | +36% |
| 2021 | $13.4 | $8.71 | -35% |
| 2022 | $8.71 | $3.97 | -54% |
| 2023 | $3.97 | $6.03 | +52% |
| 2024 | $6.03 | $22.9 | +280% |
| 2025 | $22.9 | $72.0 | +214% |
| 2026 YTD | $72.0 | $34.5 | -52% |
ASTS has the edge over IMXI on returns for 2026, with the stronger performance.
IMXI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $12.0 | $15.9 | +32% |
| 2021 | $15.9 | $15.8 | -0.6% |
| 2022 | $15.8 | $22.5 | +43% |
| 2023 | $22.5 | $22.1 | -1.6% |
| 2024 | $22.1 | $20.6 | -6.6% |
| 2025 | $20.6 | $15.4 | -25% |
| 2026 YTD | $15.4 | $6.39 | -59% |
IMXI has finished three years in a row lower, and it's down 59% so far in 2026.